@misc{indiciae8535ae814f87,
  title = {EZH1/2 inhibition improves immunotherapy response through MHC Class II de-repression and neutrophil reprogramming},
  author = {Childress, A. R. and Esoe, D.-P. I. and Song, X. and Gosser, C. M. and Lin, Y. and Plaugher, D. R. and DuCote, T. J. and Naughton, K. J. and Skaggs, E. M. and Yang, H. and Goettl, R. and Liu, J. and Hao, Z. and Fliss, A. E. and Honma, D. and Burus, T. and Lei, F. and Huang, B. and Beswick, E. and Brainson, C. F.},
  year = {2026},
  doi = {10.64898/2026.06.01.725956},
  url = {https://www.biorxiv.org/content/10.64898/2026.06.01.725956v1},
  note = {Source identifier: 10.64898/2026.06.01.725956}
}